Dr. Venkatachala Mohan
Claim this profileWashington Gastroenterology- GIA
Studies Crohn's Disease
Studies Ulcerative Colitis
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Venkatachala Mohan is currently running
Vedolizumab + Adalimumab/Ustekinumab
for Crohn's Disease
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab together with ustekinumab in adults with moderate to severe Crohn's Disease, and the effect of treatment with vedolizumab alone, after the dual targeted treatment. The study is conducted in two parts. In Part A, participants will receive the dual targeted treatment (vedolizumab together with either adalimumab or ustekinumab). In part B, participants will receive vedolizumab only. Part B will include participants who responded to the treatment in Part A. Each participant will be followed up for at least 26 weeks after the last dose of treatment.
Recruiting3 awards Phase 410 criteria
Vedolizumab + Tofacitinib
for Ulcerative Colitis
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim is to learn about treatment with Vedolizumab alone after the double treatment. All participants will receive vedolizumab together with tofacitinib for 8 weeks and will be checked for response. Participants who show a response to the treatment after 8 weeks will be treated with vedolizumab alone for an additional 44 weeks. Each participant will be followed up for at least 26 weeks after the last dose of vedolizumab.
Recruiting3 awards Phase 47 criteria
More about Venkatachala Mohan
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Venkatachala Mohan has experience with
- Vedolizumab
- CDPATH™
- Tofacitinib
- Adalimumab
- Ustekinumab
Breakdown of trials Venkatachala Mohan has run
Crohn's Disease
Ulcerative Colitis
Inflammatory Bowel Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Venkatachala Mohan specialize in?
Venkatachala Mohan focuses on Crohn's Disease and Ulcerative Colitis. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is Venkatachala Mohan currently recruiting for clinical trials?
Yes, Venkatachala Mohan is currently recruiting for 2 clinical trials in Bellevue Washington. If you're interested in participating, you should apply.
Are there any treatments that Venkatachala Mohan has studied deeply?
Yes, Venkatachala Mohan has studied treatments such as Vedolizumab, CDPATH™, Tofacitinib.
What is the best way to schedule an appointment with Venkatachala Mohan?
Apply for one of the trials that Venkatachala Mohan is conducting.
What is the office address of Venkatachala Mohan?
The office of Venkatachala Mohan is located at: Washington Gastroenterology- GIA, Bellevue, Washington 98004 United States. This is the address for their practice at the Washington Gastroenterology- GIA.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.